Bifurcation analysis of insulin regulated mTOR signalling pathway in cancer cells.

IET Systems Biology
Krishnamachari Sriram

Abstract

Insulin induced mTOR signalling pathway is a complex network implicated in many types of cancers. The molecular mechanism of this pathway is highly complex and the dynamics is tightly regulated by intricate positive and negative feedback loops. In breast cancer cell lines, metformin has been shown to induce phosphorylation at specific serine sites in insulin regulated substrate of mTOR pathway that results in apoptosis over cell proliferation. The author models and performs bifurcation analysis to simulate cell proliferation and apoptosis in mTOR signalling pathway to capture the dynamics both in the presence and absence of metformin in cancer cells. Metformin is shown to negatively regulate PI3K through AMPK induced IRS1 phosphorylation and this brings about a reversal of AKT bistablity in codimension-1 bifurcation diagram from S-shaped, related to cell proliferation in the absence of drug metformin, to Z-shaped, related to apoptosis in the presence of drug metformin. The author hypothesises and explains how this negative regulation acts a circuit breaker, as a result of which mTOR network favours apoptosis of cancer cells over its proliferation. The implication of reversing the shape of bistable dynamics from S to Z or vice-v...Continue Reading

References

Mar 8, 2000·Journal of Theoretical Biology·J L Cherry, F R Adler
Mar 22, 2003·Current Opinion in Cell Biology·John J TysonBela Novak
Jul 21, 2004·Progress in Biophysics and Molecular Biology·Herbert M Sauro, Boris N Kholodenko
Mar 1, 2005·Biochimie·Philippe GualJean-François Tanti
Mar 3, 2005·The Journal of Chemical Physics·Anke Sensse, Markus Eiswirth
Feb 17, 2006·Nature Reviews. Molecular Cell Biology·Boris N Kholodenko
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Oct 26, 2006·Cancer Research·Mahvash ZakikhaniMichael Pollak
Jul 7, 2007·Cancer Cell·David A Guertin, David M Sabatini
Oct 13, 2007·Nature Reviews. Drug Discovery·Robyn P AraujoEmanuel F Petricoin
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Oct 9, 2009·Journal of Cell Science·Mathieu Laplante, David M Sabatini
Dec 1, 2009·Current Opinion in Cell Biology·Alejo Efeyan, David M Sabatini
Feb 6, 2010·Breast Cancer Research and Treatment·Mahvash ZakikhaniMichael N Pollak
Dec 16, 2010·Nature Reviews. Molecular Cell Biology·Roberto ZoncuDavid M Sabatini
Dec 24, 2010·Science Signaling·Oliver E SturmWalter Kolch
Jul 10, 2012·Nature Medicine·Kıvanç BirsoyRichard Possemato
Sep 23, 2014·Trends in Biochemical Sciences·James E Ferrell, Sang Hoon Ha
Dec 3, 2014·Trends in Biochemical Sciences·James E Ferrell, Sang Hoon Ha
Dec 3, 2014·Trends in Biochemical Sciences·James E Ferrell, Sang Hoon Ha
Oct 21, 2015·Seminars in Cell & Developmental Biology·Lan K Nguyen, Boris N Kholodenko
Oct 18, 2016·Cancer Medicine·Mohamed AlalemBimal K Ray
Mar 12, 2017·Cell·Robert A Saxton, David M Sabatini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

© 2022 Meta ULC. All rights reserved